Rocket Pharmaceuticals (RCKT) Long-Term Debt Issuances (2014 - 2016)

Rocket Pharmaceuticals (RCKT) has 3 years of Long-Term Debt Issuances data on file, last reported at -$52.0 million in Q4 2016.

• For the quarter ending Q4 2016, Long-Term Debt Issuances fell 442.01% year-over-year to -$52.0 million; the trailing twelve-month figure through Dec 2016 stood at -$52.0 million (down 347.55% YoY), and the FY2016 full-year result was $14000.0, down 99.93% from the prior year.
• Long-Term Debt Issuances fell to -$52.0 million in Q4 2016, from $15.2 million in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $21.0 million in Q1 2015 to a low of -$52.0 million in Q4 2016.
• A 3-year average of -$6.1 million and a median of $715000.0 in 2014 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances jumped 2025.87% in 2015 and sank 442.01% in 2016, its largest moves.
• Tracing RCKT's Long-Term Debt Issuances over 3 years: stood at $715000.0 in 2014, then jumped by 2025.87% to $15.2 million in 2015, then slumped by 442.01% to -$52.0 million in 2016.
• Business Quant data shows RCKT's Long-Term Debt Issuances at -$52.0 million in Q4 2016, $15.2 million in Q4 2015, and -$15.2 million in Q2 2015.